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BUWALDA, B., C. NYAKAS, J. M. KOOLHAAS, P. G. M. LUITEN AND B. BOHUS. Vasopressin prolongs behavioral and 
cardiac responses to mild stress in young but not in aged rats. PHYSIOL BEHAV 52(6) 1127-1131, 1992.--In young male Wistar 
rats sudden silence superimposed on low intensity background noise evokes a relative decrease in heart rate. This bradycardia is 
accompanied by immobility behavior. In the present study, involving young (3 month), late-adult (14 month), aged (20 month), 
and senescent  (25 month) rats the magnitude of  the stress-induced  bradycardia shows an age-related  reduction while  the behavioral 
immobility response remained unchanged during the process of aging. Arginine-8-vasopressin  (AVP, 6 #g/kg SC) administered 
60 rain prior to the experiment led to a prolonged behavioral and cardiac stress response in young and late-adult rats, but not in 
aged and senescent  animals. The peripheral and central mechanisms possibly  involved in the failure of systemically  applied AVP 
to improve bradycardiac stress responses in aged rats are discussed. 
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THE neurohypophyseal peptide arginine-8-vasopressin (AVP) 
modifies various forms of learned behavior, apart from its well- 
known classical endocrinological actions. Several studies showed 
that both systemically  and centrally administered AVP prolongs 
extinction and improves consolidation and retrieval processes 
in avoidance learning  tasks (10,19,23,25,37).  A number  of studies 
have focussed  on the effects of AVP on physiological responses 
related to emotion and behavioral adaptation (4,5,20).  Experi- 
ments in freely behaving adult rats in various stressful situations 
showed that AVP serves  as an important modulator of a bra- 
dycardiac response to an emotional stressor (4,20). Because this 
stress-induced bradycardia appears to be vagally mediated (8), 
these experiments suggest that AVP is involved in a neural net- 
work that serves  a  parasympatheticaUy regulated response to 
stress. 
Previous research in this laboratory focussed on the age-re- 
lated changes in the autonomic responses due to stressors  in- 
ducing behavioral immobility (30). During this passive way of 
coping, young male Wistar rats reacted predominantly with a 
vagaUy mediated cardioinhibitory  response. While the behavioral 
responsiveness to stress remained intact, the initial  bradycardiac 
response appeared to be diminished in aged rats (30). Therefore, 
an age-related attenuation of parasympathetic control of cardiac 
functioning  during emotional stress situations  was suggested (30). 
Peripherally applied AVP appeared to reinstate the bradycardiac 
response to a conditioned stress of fear of inescapable footshock 
in 14-month-old male Wistar rats (5,29).  These results led to 
the hypothesis that AVP-dependent mechanisms are involved 
in the age-related reduction of stress-induced parasympathetic 
responsiveness. Because  the bradycardiac response to  condi- 
tioned aversive stimuli is thought to reflect the attentional de- 
mands of the experimental situation (31), one would expect a 
comparable action of AVP in nonaversive  conditions  that result 
in vagal activation due to acute orientation/attention  behavior. 
Sudden silence superimposed on low intensity background noise 
is eliciting bradycardia and immediate behavioral arrest in young 
rats (18). In a previous study, AVP was demonstrated to enhance 
behavioral and cardiac responses to this sudden silence stress in 
young male rats, whereas it failed to improve or even worsened 
such responses in 24-month-old rats (7). 
The aim of this paper was to analyze the modulating prop- 
erties of AVP on behavioral and cardiac responses to the mild 
stress of sudden silence not only in young and old rats, but also 
in rats of intermediate ages to study at which moment a hypo- 
sensitivity to vasopressinergic modulation of stress-related be- 
havior and cardiac control develops during the process of aging. 
METHOD 
Animals and Housing 
Male Wistar rats of four different ages were used. The animals 
were 4,  14,  20,  and 25  months old and originated from the 
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Winkelman  substrain  (kindly  donated  by  Troponwerkc,  Col- 
ogne, Germany). They were housed six to a cage (40 ×  60 X  15 
cm),  with  food and  water ad  lib, in  a  temperature-controlled 
environment of 21  _+ 2°C: the lights were on from 0730 to 1930 
h. All experiments were performed between 0900 to  1300 h. 
Surgeo" 
In order to record the electrocardiogram  (ECG), transcuta- 
neous stainless steel electrodes made of standard  paperclips were 
implanted under light ether anesthesia. One electrode was placed 
between the scapulae and the other in the midback  region, ac- 
cording to the method described previously (3). At least 3 days 
were allowed for recovery before the start of the experiment. 
Recording and Analysis of the ECG 
The ECG of freely moving rats was monitored telemetrically 
by  means  of a  miniature  FM transmitter  (model  SNR  102F, 
Dynamic Electronics Ltd., London, England) as described before 
(3).  The  transmitter  was  attached  to  a  velcrose strap  secured 
around the chest of the rat and connected to the transcutaneous 
electrodes.  The  transmitted  signals  were  received  on  a  com- 
mercial FM  receiver, amplified (Narco  Bio-System Inc.  Mod. 
FM-1100-7), and stored on tape by a commercial tape recorder. 
During recording and  analysis,  the quality  of the ECG signal 
was continuously monitored on an oscilloscope. 
Recorded ECG samples were played back through a cardio- 
tachometer  pulsegenerator  (Schmitt-trigger)  that  generated  a 
square wave pulse at each R  wave. The interbeat interval (IBI), 
i.e., the time elapsed between onset of the two consecutive pulses, 
was measured  using a  personal  computer (Olivetti M24).  The 
mean IBis were computed for periods of 55 s. IBis shorter than 
100 and longer than 220 ms were discarded because these were 
likely to be due to artifacts. 
Procedure 
The behavioral and cardiac  responses to a  sudden  drop  in 
background noise were measured in a rectangular clear Plexiglas 
cage (85  ×  60  ×  60  cm),  designated  as an  open  field in this 
paper. This open field with a wood shavings covered floor was 
located in an acoustically isolated experimental room where a 
noise generator produced  a  background  noise that  was main- 
tained at a  constant  level (65 dB,  2-8  kHz).  Upon entering, a 
velcro strap  holding a  miniature  FM-transmitter  for the ECG 
recordings was fixed around the chest of the rat. The animal was 
placed in the open field for 5 min on day  1. On day 2, the test 
day, the animals were exposed again to the open field for 5 min. 
After 2 min the background noise was switched off, leaving the 
animal in almost total silence for the remaining  3 min. Heart 
rate and behavior were recorded for three periods (P) of 60 s. 
Second-min recordings were made during the 60 s immediately 
prior to switching off the background noise (P1). Third-min re- 
cordings (P2)  during the 60  s  immediately after switching off 
the noise (P2) and fifth-min recordings (P3) were regarded,  re- 
spectively, as  response  and  recovery measurements.  As a  be- 
havioral measure, the time spent immobile was determined by 
an observer during the three periods. Immobility was defined as 
almost motionless scanning of the environment with only minor 
head movements. 
Treatment 
Arginine-vasopressin (AVP) was dissolved in saline and in- 
jected subcutaneously  (SC) in a  dosage of 6  ~g/kg/ml 60 min 
prior to the exposure to the open field. Saline injections served 
as vehicle. The selection of the single dose of the peptide was 
based  on the results of the previous studies of }oLlng and aged 
rats'  cardiac  response  to emotional  stress  (29)  and  on  several 
other studies describing behavioral and  physiological effects of 
peripherally applied  AVP (20-22,24,25).  EEG  recordings (I 3) 
further indicated a similarity between SC administered  AVP in 
a dose of 6 ug/kg and a  behaviorally relevant  intracerebroven- 
tricular administered  dose of 1 ng.  The rats  were iniccted  m  a 
crossover design with saline or AVP, each animal serving as its 
own control. A 7-day wash-out period was allowed between in- 
jections to minimize interaction of treatments. 
Slatistic.~ 
]he results are presented as means ±  SEM in two measures; 
absolute values are presented  in the figures and  response (P2- 
PI) and recovery (P2-P3) values in the table. The absolute car- 
diac data were analyzed using a multivariate ANOVA (two-way) 
utilizing one between-subjects factor (group) and one repeated 
measures within-subjects factor (periods), a two-tailed Student's 
t-test  and  a  paired  t-test.  Response  and  recovery  values were 
analyzed using a one-way ANOVA utilizing the factor age. Be- 
havioral data were evaluated for significance using the Kruskal- 
Wallis ANOVA and the Wilcoxon matched-pairs  ranked-signs 
test. A  probability level ofp <  0.05 was taken as statistical sig- 
nificance for all tests. 
RESULTS 
Vasopressinergic Modulation of Cardiac Stress Responses 
Figure 1 shows the heart rate values, expressed as IB1, of the 
animals in the open field and the cardiac response to stress of 
sudden  silence.  ANOVA  testing  revealed  no  effect of age  on 
presilence,  i.e.,  prestress  values during  PI.  The  magnitude  of 
response as well as the recovery, values after sudden cessation of 
background noise are presented in Table 1. Multivariate ANOVA 
with repeated measures for the three periods showed no signif- 
icant age effect in vehicle-treated animals, but a highly significant 
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FIG.  I. Heart rate expressed  as interbeat interval (IBI) during a 5-min 
exposure  to an open field before and after sudden reduction of a non- 
aversive background mixed noise, measured in 4 (n = 9), 14 (n = 9), 20 
(n = 8) and 25 (n =  I l)-month-old male Wistar rats. One-min recordings 
were made during the second min of exposure to the open field with the 
noise on (Pl); during the third min immediately after the noise was 
switched off (P2), and during the fifth rain (P3). IBis are presented after 
subcutaneous administration of saline (open circles) and AVP (closed 
circles). Means +_ SE are shown. VASOPRESSIN,  STRESS,  AND  AGING  1129 
interaction between age and periods, F(2, 64) =  4.7, p  = 0.0007. 
Although all vehicle-treated age groups showed a significant car- 
dioinhibitory response, i.e., an increase in IBI, to switching off 
the noise, the magnitude of this response (see Table  1) showed 
an age-related decrease, F(3, 32) =  6.27, p  =  0.002.  Recovery, 
measured as the difference in IBI between P3 and P2 was also 
reduced in aging, F(3, 32) =  6.73, p  =  0.002. 
Administration of AVP caused a decrease in heart rate already 
before the reduction of background  noise, i.e., P1, in the open 
field in all age groups, expressed in a significant treatment effect, 
F(1, 65) =  21.7, p  <  0.001. There was no significant interaction 
between  age  and  treatment  on  prestress  values.  Multivariate 
ANOVA for the factors age by treatment by periods also showed 
no  significance.  The  interaction  between  age  and  periods  as 
shown after vehicle treatment disappeared  after AVP adminis- 
tration, suggesting an effect of the treatment throughout the pe- 
riods.  This is caused by the absence of recovery during  P3  of 
the cardiac stress response in 4- and 14-month-old rats receiving 
AVP. A  significant interaction between treatment  and periods 
was observed in 4-, F(2, 32) =  5.88, p  =  0.007, and  14-month- 
old rats, F(2, 32) =  3.17, p  =  0.05. Twenty- and 25-month-old 
rats failed to show this interaction. 
Vasopressinergic Modulation of Behavioral Stress Responses 
ANOVA testing revealed no significant age or treatment effect 
on prestress immobility values. Neither was an interaction be- 
tween age and treatment present during P 1. Figure 2 shows that 
all  vehicle-treated  animals  responded  to  sudden  cessation  of 
background noise with an increase in immobility behavior (see 
also Table 1). ANOVA (Kruskal-Wallis) indicated that neither 
the magnitude of the response nor the recovery after the sudden 
stimulus change were affected by age. Only 20-month-old ani- 
mals failed to show a significant recovery of immobility behavior 
after stress. 
After AVP administration there was an effect of age on im- 
mobility responses, H(3, 37) =  14.95, p  =  0.002. Post hoc testing 
indicated that in  14-month-old rats AVP increased the immo- 
bility response  (p  <  0.05),  whereas  in  25-month-old  rats  the 
behavioral stress response was reduced (p <  0.01).  A  two-way 
ANOVA showed  a  significant interaction  between the factors 
4£ 
Z- 
5£ 
20 
10 
I  I  I 
P1  P2  P3 
/4 
I  I  I  I  I  I  I  I  I 
P1  P2  P3  P1  P2  P3  P1  P2  P3 
periods 
FIG. 2. Behavioral  immobility in the open field before (PI) and after 
sudden silence (P2 and P3) in 4-,  14-, 20-, and 25-month-old rats. For 
further information see Fig.  1. 
age and treatment  on immobility responses,  F(3,  65)  =  2.8, p 
=  0.04. 
DISCUSSION 
The present findings indicate that between the age of 14 and 
20 months,  male Wistar rats develop a  hyposensitivity to AVP 
in modifying the behavioral and cardiac response to mild un- 
expected stress. 
AVP caused a reduction in heart rate in all age groups already 
before the sudden reduction of background noise. This may be 
the result ofa baroreceptor reflex-induced vagal activation. That 
this alternative is unlikely is suggested by our former study (29). 
Sixty min  after peripheral  administration  of 10  ~g/kg AVP a 
moderate  bradycardia  was  found  in  rest  conditions,  together 
with a slightly decreased blood pressure.  Lebrun et al. (24) also 
showed that the systolic pressor response to 6  ~tg/kg AVP dis- 
TABLE 1 
RESPONSE VALUES  TO (P2-PI) AND RECOVERY  AFTER (P2-P3) THE SUDDEN CESSATION 
OF BACKGROUND  NOISE  AFCER  SALINE  OR AVP APPLICATION 
Response to Sudden Silence  Recovery  After Sudden Silence 
Rat Age  AIBI (ms)  Almmobility  (s)  AIBI (ms)  Almmobility  (s) 
4 Months 
SAL  15.4 + 3.7  26.2 _+ 3.6  14.1 +  3.6  28.0 _+  6.3 
AVP  18.1 + 4.2  30.3 + 5.4  1.7 +  3.7*  8.7 _+ 6.0t 
14 Months 
SAL  10.0 _+ 1.7  24.9 + 6.1  7.2 +  1.6  14.7 _+  7.0 
AVP  18.8 + 4.7  37.4 + 4.4 t  0.9 _+ 5.2  6.2 +  5.8 
20 Months 
SAL  4.8 +  1.8  19.0 + 6.2  -2.1  + 4.0  -0.1  +  14.0 
AVP  5.2 + 2.7  13.9 + 5.4  -0.7 +  3.8  -5.0 +  6.2 
25 Months 
SAL  3.5 + 0.9  23.7 + 3.6  2.3 +  1.1  16.4 _+  4.3 
AVP  6.0 +  3.0  8.7 +  5.0*  -1.2 _+ 2.0  0.7 _+  4.4* 
"1" Within the age group the response  and recovery values after AVP administration were 
compared with the animals' own vehicle control value by means of a paired t-test (cardiac 
data) or a Wilcoxon matched pairs-ranked signs test (behavioral data), *p < 0.01, tP < 0.05. 1130  B[I~,~,.AIII~  I  ~l  :',i 
appears  within 60 min after administration.  Therefore, the re- 
duction of heart rate may be caused by a direct action of vaso- 
pressin  on  the  heart  (14,35)  through  effects of the peptide  on 
coronary  blood  flow and  oxygen  availability  within  the  myo- 
cardium (2,27). 
In addition  to the general reduction  in heart  rate,  AVP ex- 
tended the bradycardiac stress response in 4- and  14-month-old 
animals. These data support the finding of an effect of AVP on 
acute cardiac stress responses in young rats as described previ- 
ously (20). 
Administration  of AVP enhanced the magnitude of the be- 
havioral immobility response to stress in 14-month-old animals, 
whereas  it decreased  this response  in  25-month-old  rats.  This 
differential age-related effect of AVP on the behavioral immo- 
bility responses is reflected in the significant interaction between 
age and treatment.  Peptide treatment further prolonged the du- 
ration of immobility behavior in 4-month-old animals. 
Both centrally (10) and peripherally (25) located mechanisms 
are hypothesized to be involved in vasopressinergic modulation 
of stress-related  autonomic and behavioral responses.  The ex- 
tension  of the bradycardiac  stress responses may reflect a  sen- 
sitization of baroreflex control  of circulation (16),  No data are 
available, however, on age-related changes in the vasopressinergic 
modulation  of these  reflexes.  In  numerous  studies  changes  of 
vasopressinergic innervation patterns in the brain of aged rodents 
was shown  [for review see (36)].  Age-related changes  in  vaso- 
pressin cells in the suprachiasmatic  nucleus were reported (34). 
Dorsa and Bottemiller (12) found decreased AVP concentrations 
in a number of intra- and extrahypothalamic areas in aged rats, 
e.g., in septum, the vascular organ of the lamina terminalis, and 
the locus coeruleus.  A  study  of Fliers et al.  (15)  revealed that 
age-related reduction in vasopressinergic innervation occurs in 
many areas of the brain controlling behavioral and autonomic 
responses.  Only a  few studies have been devoted to the effects 
of exogenous AVP in behavioral tasks in aged animals.  While 
the present  study  addresses  the effects of AVP on attentional 
processes,  most  of these  studies  involve age-related  effects of 
AVP on  memory  measures.  In  late-adult  rats  (13-14-months 
old) AVP enhanced cardiac and behavioral stress responses (5) 
and improved memory function (37). Cooper et al. (9) showed 
that AVP facilitated the conditioned taste aversion  in  19- and 
24-month-old rats. 
While the present findings in the younger groups confirm the 
reported  effects of AVP on behavioral and  autonomic  perfor- 
mance (5,20,25), the failure of the peptide to elicit similar effects 
in aged rats indicate a decreased sensitivity to AVP in these old 
animals. A cause of the vasopressinergic hyposensmvity in aged 
rats may be a decreased sensitivity or number of vasopressinergic 
receptors  during  aging.  No  information  to  our  knowledge  is 
available yet about  age-related  alterations  in the properties  of 
vasopressinergic receptors  in the brain.  Peripherally.  however, 
a strong decrease in vasopressin binding was tbund in the kidney 
(33) and the liver (26) of aged rats. Administration ofAVP thiled 
to  correct  the  impaired  urine  concentration  in  aged  rats  (l/. 
indicating  the  decreased  sensitivity  of the  aged  kidney  to  the 
antidiuretic effect of AVP.  However, vascular smooth  muscles 
of old rats show an  increased sensitivity to AVP (17).  Accord- 
ingly, there  are probably  organ-specific differences  in  the sen- 
sitivity to vasopressin during aging, i.e., age does not affect all 
vasopressinergic  receptors  uniformly.  A  third  possible  mecha- 
nism of the reduced effect of AVP in aged rats might be related 
to  age-dependent  changes  in  receptor-stimulated  second-mes- 
senger activation (38).  There is extensive evidence that central 
and peripheral  catecholaminergic systems interact with neuro- 
peptides such as AVP in the modulation  of behavior (6,23,32). 
Because peripherally applied d-amphetamine enhances the bra- 
dycardiac stress response in aged rats (28), it is also possible that 
AVP  indirectly  modulates  the  cardiodecelerato~'  response  to 
emotional stress through activation of aminergic systems in the 
brain.  The failure of AVP to restore the bradycardia  in old an- 
imals,  therefore,  can  be related  to the reported  age-related  re- 
duced activation of central catecholaminergic systems (39). 
Whether the effects of systemically applied AVP in affecting 
cognitive processes are peripherally or centrally mediated is still 
an  issue  of major  discussion  (11,22).  Whereas  De  Wied  and 
collegues (10)  suggested a  direct central action  of vasopressin, 
Le Moal et al. (25) hypothesized that  hemodynamic  responses 
shortly after the peptide injection were causing the behavioral 
effects of AVP. Koob et al. (21 ) suggested that systemically and 
centrally  administered  AVP  can  influence  behavior  in  a  ho- 
mologous manner  but by different mechanisms  of action. Our 
data  fit with the decreased  peripheral  sensitivity, but a  central 
direct action cannot be excluded. 
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